Squarepoint Ops LLC Ardelyx, Inc. Transaction History

Squarepoint Ops LLC

$96.1 Billion
Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 396,820 shares of ARDX stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

396,820

Previous 180,711 119.59%

Holding current value

$2.33 Million

Previous $708,000 209.32%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.92 - $6.64 $847,147 - $1.43 Million	216,109 Added 119.59%	396,820 $2.19 Million
Q2 2025 Aug 14, 2025	BUY	$3.28 - $5.51 $592,732 - $995,717	180,711 New	180,711 $708,000
Q4 2024 Feb 14, 2025	SELL	$4.49 - $6.85 $85,902 - $131,054	-19,132 Reduced 54.46%	16,000 $82,000
Q3 2024 Nov 14, 2024	SELL	$5.28 - $7.57 $2.25 Million - $3.22 Million	-425,557 Reduced 92.37%	35,132 $242,000
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $2.14 Million - $3.39 Million	363,894 Added 375.94%	460,689 $3.41 Million

Q1 2024 May 15, 2024	SELL	$6.05 - $9.74 $1.39 Million - $2.24 Million	-229,494 Reduced 70.33%	96,795 $706,000
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $1.07 Million - $2.17 Million	326,289 New	326,289 $2.02 Million
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $679,983 - $1.22 Million	253,725 New	253,725 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$0.51 - $1.17 $5,795 - $13,295	11,364 New	11,364 $7,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $18,728 - $37,020	-21,777 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $27,656 - $177,918	21,777 New	21,777 $29,000
Q1 2021 May 17, 2021	SELL	$6.1 - $7.69 $515,175 - $649,458	-84,455 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $30,426 - $42,777	-6,025 Reduced 6.66%	84,455 $546,000
Q3 2020 Nov 16, 2020	SELL	$5.25 - $7.08 $21,063 - $28,404	-4,012 Reduced 4.25%	90,480 $475,000
Q2 2020 Aug 14, 2020	SELL	$5.37 - $8.11 $142,122 - $214,639	-26,466 Reduced 21.88%	94,492 $654,000
Q1 2020 May 15, 2020	SELL	$4.35 - $8.79 $605,489 - $1.22 Million	-139,193 Reduced 53.5%	120,958 $688,000
Q4 2019 Feb 14, 2020	BUY	$4.23 - $8.29 $1.03 Million - $2.01 Million	242,965 Added 1413.74%	260,151 $1.95 Million
Q3 2019 Nov 14, 2019	SELL	$2.15 - $6.28 $80,068 - $233,873	-37,241 Reduced 68.42%	17,186 $81,000
Q2 2019 Aug 14, 2019	SELL	$2.49 - $3.73 $532,095 - $797,074	-213,693 Reduced 79.7%	54,427 $146,000
Q1 2019 May 15, 2019	SELL	$1.88 - $3.35 $12,919 - $23,021	-6,872 Reduced 2.5%	268,120 $751,000
Q4 2018 Feb 14, 2019	BUY	$1.66 - $4.16 $164,530 - $412,318	99,115 Added 56.35%	274,992 $492,000
Q3 2018 Nov 14, 2018	BUY	$3.75 - $4.65 $517,788 - $642,058	138,077 Added 365.28%	175,877 $765,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $139,860 - $219,240	37,800 New	37,800 $140,000
Q1 2018 May 15, 2018	SELL	$5.05 - $7.9 $99,631 - $155,859	-19,729 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.85 - $7.8 $95,685 - $153,886	19,729	19,729 $130,000

Others Institutions Holding ARDX

# of Institutions

244

Shares Held

161M

Call Options Held

697K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Ardelyx, Inc. Transaction History